| 1.16 -0.03 (-2.52%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.46  |
1-year : | 1.63 |
| Resists | First : | 1.25 |
Second : | 1.39 |
| Pivot price | 1.16 |
|||
| Supports | First : | 1 |
Second : | 0.84 |
| MAs | MA(5) : | 1.18 |
MA(20) : | 1.15 |
| MA(100) : | 0.95 |
MA(250) : | 1.28  |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 40 |
D(3) : | 43.1 |
| RSI | RSI(14): 53.3 |
|||
| 52-week | High : | 10.07 | Low : | 0.37 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AEON ] has closed above bottom band by 49.3%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.21 - 1.22 | 1.22 - 1.22 |
| Low: | 1.13 - 1.13 | 1.13 - 1.14 |
| Close: | 1.15 - 1.16 | 1.16 - 1.17 |
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Tue, 27 Jan 2026
Profit Review: Is AEON Biopharma Inc in a long term uptrend - Market Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Thu, 22 Jan 2026
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Wed, 21 Jan 2026
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Wed, 21 Jan 2026
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Wed, 21 Jan 2026
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Tue, 13 Jan 2026
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|